{"anticipatedPostingDate":"2028-06","denomUnitsSelected":"Participants","reportingStatus":"NOT_POSTED","timeFrame":"From Cycle 1 Day 1 up to 7 years","title":"Number of Participants With Anti-JNJ-68284528 Antibodies on Participants Who Received Cilta-cel as Study Treatment (Arm B)","type":"SECONDARY"}